Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Imazio

Showing results (451-460 of 483) with videos related to

Pageof 49
Sort By:
European Heart Journal|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
JAMA|August 31, 2014
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trialMassimo Imazio, Antonio Brucato, Paolo Ferrazzi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 20, 2025
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of CardiologyLucia Ilaria Birtolo, Gianluca Di Pietro, Fabrizio D'Ascenzo, et al.
The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.
Journal of the American Heart Association|May 6, 2026
Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study)Chiara Baggio, Antonio Cannata, Alessio Gasperetti, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
European Heart Journal. Cardiovascular Imaging|February 4, 2025
The role of cardiovascular multimodality imaging in the evaluation of Anderson-Fabry disease: from early diagnosis to therapy monitoringMatteo Cameli, Maurizio Pieroni, Maria Concetta Pastore, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
ESC Heart Failure|February 23, 2026
Colchicine in patients with chronic inflammatory cardiomyopathy: Rationale and design of the CMP-MYTHiCEnrico Ammirati, Iside Cartella, Michele Ciabatti, et al.
Pageof 49

Showing results (451-460 of 483) with videos related to

Sort By:
Pageof 49
European Heart Journal|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
JAMA|August 31, 2014
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trialMassimo Imazio, Antonio Brucato, Paolo Ferrazzi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 20, 2025
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of CardiologyLucia Ilaria Birtolo, Gianluca Di Pietro, Fabrizio D'Ascenzo, et al.
The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.
Journal of the American Heart Association|May 6, 2026
Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study)Chiara Baggio, Antonio Cannata, Alessio Gasperetti, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
European Heart Journal. Cardiovascular Imaging|February 4, 2025
The role of cardiovascular multimodality imaging in the evaluation of Anderson-Fabry disease: from early diagnosis to therapy monitoringMatteo Cameli, Maurizio Pieroni, Maria Concetta Pastore, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
ESC Heart Failure|February 23, 2026
Colchicine in patients with chronic inflammatory cardiomyopathy: Rationale and design of the CMP-MYTHiCEnrico Ammirati, Iside Cartella, Michele Ciabatti, et al.
Pageof 49